Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Suda Pharmaceuticals.
RELATED STOCKHEAD STORIES
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Dr Boreham’s Crucible: Is Suda back on track after securing first TGA approval?
Health & Biotech
World-renown cancer institute to investigate Kazia Therapeutics drug
News
10 at 10: These ASX stocks are vying for silverware this morning
Stockhead TV
StockTalk: Drug delivery tech offers patients, investors massive upside
Health & Biotech
Drug delivery technology: How it works, and the ASX companies with plans to capitalise
Guides
Cannabis stocks guide: Here’s everything you need to know
Health & Biotech
Weed week: Cannabis researchers are still split on matters of the heart
Health & Biotech
Check up: Maybe next week will be better?
Experts
Scopo’s powerplays: Hemp hippies and wellness wonderlands
News
Closing Bell: Today’s biggest small cap movers on the ASX
News
ASX Small Cap Lunch Wrap: Who’s moonlighting today?
Health & Biotech
Suda shares triple after TGA approves first mouth spray product
News
10 at 10: These ASX stocks are pollinating this morning
Experts
Scopo’s powerplays: It just won’t go down!
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech